Insider · CIK 0001898799

Buten Matthew

Reports to the SEC for 2 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001898799

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-27	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,000
2026-01-05	BHVNBiohaven Ltd.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,250 sh	—	—	198,246
2026-01-05	BHVNBiohaven Ltd.F Tax Payment	Chief Financial Officer	FTax Payment	−2,594 sh	$9.93	−$25.8K	195,652
2026-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,250 sh	—	—	8,500
2025-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,250 sh	—	—	12,750
2025-01-05	BHVNBiohaven Ltd.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,250 sh	—	—	196,013
2025-01-05	BHVNBiohaven Ltd.F Tax Payment	Chief Financial Officer	FTax Payment	−2,561 sh	$38.64	−$99K	193,452
2025-01-05	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+104K sh	—	—	104,000
2025-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardA Award	Chief Financial Officer	AAward	+17K sh	—	—	17,000
2024-01-02	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+96.3K sh	—	—	96,250
2023-11-02	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+78.8K sh	—	—	78,750
2023-10-05	BHVNBiohaven Ltd.P Purchase	Chief Financial Officer	PPurchase	+22.7K sh	$22.00	+$500K	189,380
2022-10-25	BHVNBiohaven Ltd.P Purchase	Chief Financial Officer	PPurchase	+143K sh	$10.50	+$1.5M	166,653
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−37.5K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−6,177 sh	$148.50	−$917K	0
2022-10-03	BHVNBiohaven Ltd.J Other	Chief Financial Officer	JOther	+3,088 sh	—	—	3,088
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	Chief Financial Officer	JOther	+11.5K sh	—	—	11,450
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,550 sh	$6.37	+$9,873.5	23,388
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+11.5K sh	$6.37	+$72.9K	34,838
2022-10-03	BHVNBiohaven Ltd.F Tax Payment	Chief Financial Officer	FTax Payment	−11K sh	$7.50	−$82.8K	23,796
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	Chief Financial Officer	JOther	+1,550 sh	—	—	1,550
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−3,100 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−22.9K sh	—	—	0
2022-10-03	BHVNBiohaven Ltd.J Other	Chief Financial Officer	JOther	+18.8K sh	—	—	21,838
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,550 sh	—	—	0
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−11.5K sh	—	—	0
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+300K sh	—	—	300,000
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+26K sh	—	—	26,000
2021-12-31	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	37,500
2021-12-31	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Financial Officer	FTax Payment	−6,323 sh	$137.81	−$871K	6,177
2021-12-31	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	—	—	12,500
2021-12-08	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardA Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Mar 34
Buten Matthew0001898799-26-000004
SEC(opens sec.gov)
Jan 74
Buten Matthew0001898799-26-000002
SEC(opens sec.gov)
Jan 74
Buten Matthew0001935979-25-000003
SEC(opens sec.gov)
Jan 44
Buten Matthew0001562180-24-000284
SEC(opens sec.gov)
Nov 64
Buten Matthew0001562180-23-007580
SEC(opens sec.gov)
Oct 64
Buten Matthew0001562180-23-007229
SEC(opens sec.gov)
Oct 264
Buten Matthew0001562180-22-007333
SEC(opens sec.gov)
Oct 54
Buten Matthew0001562180-22-007076
SEC(opens sec.gov)

Companies

Address

C/O BIOHAVEN LTD. 215 CHURCH STREET

NEW HAVEN, CT, 06510